Stockholders’ Equity (Details)																						1 Months Ended																				12 Months Ended
	Dec. 14, 2021 USD ($) shares	Dec. 03, 2021 USD ($) shares	Nov. 15, 2021 USD ($) shares	Nov. 05, 2021 USD ($) shares	Oct. 25, 2021 USD ($) $ / shares shares	Aug. 15, 2021 USD ($) shares	Jul. 15, 2021 USD ($) shares	Feb. 04, 2021	Feb. 03, 2021 USD ($) shares	Feb. 01, 2021 USD ($) shares	Jan. 14, 2021 USD ($) shares	Dec. 14, 2020 USD ($) shares	Oct. 08, 2020 USD ($) shares	Sep. 11, 2020 USD ($) shares	Aug. 15, 2020 USD ($) shares	Jul. 03, 2020 USD ($) shares	May 13, 2020 USD ($) shares	May 07, 2020 USD ($)	Mar. 13, 2020	Mar. 05, 2020 USD ($) shares	Jan. 06, 2020 USD ($) shares	Nov. 29, 2021 USD ($) shares	Sep. 15, 2021 USD ($) shares	Aug. 26, 2021 USD ($) shares	Jul. 20, 2021 USD ($) shares	Jun. 17, 2021 USD ($) $ / shares shares	Mar. 17, 2021 USD ($) shares	Feb. 26, 2021 USD ($) shares	Feb. 18, 2021 USD ($) shares	Dec. 29, 2020 $ / shares	Dec. 21, 2020 USD ($) shares	Sep. 30, 2020 USD ($) shares	Sep. 15, 2020 USD ($) $ / shares shares	Aug. 31, 2020 USD ($) shares	Aug. 21, 2020 USD ($) shares	Aug. 17, 2020	Jul. 17, 2020 shares	Jun. 29, 2020	Jun. 18, 2020 USD ($) shares	Mar. 19, 2020 USD ($) shares	Jan. 30, 2020 USD ($) shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2021 AUD ($) shares	Dec. 31, 2020 USD ($) shares	Dec. 31, 2018 USD ($) shares	Jul. 17, 2021 $ / shares shares	Jul. 09, 2021 shares	May 24, 2021 USD ($) shares	Apr. 21, 2021 USD ($) shares	Apr. 10, 2021 USD ($) shares	Mar. 31, 2021 USD ($) shares	Mar. 28, 2021 USD ($) shares	Feb. 08, 2021 USD ($) shares	Jan. 20, 2021 USD ($) shares	Jul. 13, 2020 $ / shares shares	Jul. 17, 2018 $ / shares
Stockholders’ Equity (Details) [Line Items]
Shares of capital stock | shares																																																							35,000,000
Designated of common stock shares | shares																																																							15,000,000
Common stock, par value | $ / shares					$ 0.001																																																		$ 0.001
Designated of preferred stock | shares																																																							20,000,000
Preferred stock, par value | $ / shares																																																							$ 0.001
Issuance shares of common stock | shares																																																							100,000,000
Issuance of preferred stock | shares																																																							20,000,000
Reverse stock split, description																																				On August 17, 2020, following board of director’s approval, the Company filed a Certificate of Change to its Articles of Incorporation (the “Amendment”), with the Secretary of State of the State of Nevada to effectuate a one-for-twenty (1:3) reverse stock split (the “Reverse Stock Split”) of its common stock, par value $0.001 per share, without any change to its par value.
Exercise price | $ / shares					$ 4.5																												$ 4.5																							$ 18
Converted shares | shares																																										7,278	7,278
Restricted common stock issued, shares | shares	211	194	13,392	25,000																		101,097	793						10,417
Fair value of services | $	$ 452	$ 429	$ 41,917	$ 85,750																		$ 246,676	$ 2,500						$ 50,002
Share based payments | $																																										$ 9,661,168		$ 6,861,163
Gain/Loss on settlement of vendor liabilities | $																						$ 33,217
Number of shares authorized to issue | shares																																	2,744,288
Principal | $																																	$ 7,325,000
Accrued but unpaid. | $																																	$ 967,518
Debt obligations | shares																																	500,000
Warrants issued | shares																																	331,456									19,950	19,950
Lenders notes totaling | $																																	$ 20,000
Loss on debt extinguishment | $																																	$ 4,915,327									$ 1,025,555		$ (5,586,482)
Underwritten public offering | shares																																	1,725,000
Option to purchase shares | shares																																	258,750
Warrants to purchase | shares																																	258,750
Underwriting discounts and commissions. | $													$ 2,588
Restricted common stock | shares																																																		16,275	13,113	31,782		40,000
Fair value | $																																													$ 57,123			$ 34,500	$ 3,587	$ 69,332	$ 43,667	$ 125,000	$ 7,502	$ 192,000
Additional common stock | shares																										112,500																						10,000
Stock based compensation expense | $																																										$ 99,908
Total common stock shares | shares																																																	1,048				2,092
Loss on settlement of vendor liabilities | $																																																			$ 12,719
Aggregate common stock shares | shares					850,000																																									750,000
Common stock per share | $ / shares																																														$ 3.4
Net proceeds																										$ 2,213,500																	$ 224,540
Warrants issued | shares																										46,667																1,137,575	1,137,575	3,922
Warrant exercise price | $ / shares																										$ 5.4
Additional shares of common stock | shares																																															954,568
Gross proceeds | $					$ 3,407,250
Outstanding vendor liabilities | shares																						576,783
Grant options | shares																																													11,667
Restricted stock unit grants | $																		$ 2,500,000
Fair market value percentage																		100.00%
Options previously issued | shares																	152,992
Issued common stock | shares																	229,491
Exchange of options to stock | $																	$ 1,117,031
Unvested employee options, description																																										As of December 31, 2021, there was $3,197,018 of total unrecognized compensation expense related to unvested employee options granted under the Company’s share-based compensation plans that is expected to be recognized over a weighted average period of approximately 1.23 year.	As of December 31, 2021, there was $3,197,018 of total unrecognized compensation expense related to unvested employee options granted under the Company’s share-based compensation plans that is expected to be recognized over a weighted average period of approximately 1.23 year.
Weighted average remaining life																																										1 year 2 months 23 days	1 year 2 months 23 days
Additional warrant issued | shares													258,750																													127,801	127,801
Fair value of Warrants | $																																										$ 3,258,955		$ 37,927
Deemed dividend | $																																										410,750		3,135,702
Received exercise of warrants | $																																										9,487,223
Warrants issued | shares																										80,000
Stock-based compensation for stock warrants | $																																										129,375		4,229
Stock-based compensation for stock warrants | $																																										480,863
Share-based awards, restricted stock award, description								the Company shall pay each member of the Board, for each calendar quarter during which such member continues to serve on the Board, compensation as a group amounts to $62,500 per quarter. The shares vest one year after issuance.
Stock-based compensation for RSA’s amount | $																																										$ 391,035
Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Restricted common stock issued, shares | shares						820	715		1,929	50,000	30,000	10,417			6,167	15,000				2,153	1,412		793	348	2,154		9,624	291	10,000		8,371	7,979		1,866	20,000		6,667		50,000	20,000	50,000
Fair value of services | $						$ 2,500	$ 2,500		$ 8,198	$ 196,000	$ 133,200	$ 38,647			$ 50,693	$ 204,300							$ 2,500	$ 999	$ 8,570		$ 49,371	$ 1,499	$ 48,000		$ 31,323	$ 21,304		$ 15,842	$ 180,000				$ 525,000		$ 585,000
Share based payments | $																																												$ 585,000
Restricted common stock issued to settle liabilities, value | $																				$ 25,000	$ 12,500																			$ 72,048
Gain/Loss on settlement of vendor liabilities | $																				$ 1,098	$ 4,233																			$ 122,953
Conversion of warrant, description																			The company agreed to exchange 5,833 warrants for 5,000 shares of the company common stock. In connection with this agreement the company recorded a loss on conversion of warrants to stock of $5,772.																			The company agreed to exchange 5,833 warrants for 2,239 shares of the company common stock and $10,000.
Outstanding vendor liabilities | shares																																										294,895	294,895	23,565
Stock-based compensation for stock warrants | $																																												$ (7)
Treasury Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Cancelled shares | shares																																												50,650
Warrant [Member]
Stockholders’ Equity (Details) [Line Items]
Warrants issued | shares																																										2,250,691	2,250,691
Deemed dividend | $																																												$ 18,421
Warrant to purchase of common stock | shares																																										2,414,218	2,414,218
Stock Option [Member]
Stockholders’ Equity (Details) [Line Items]
Share based payments | $																																										$ 7,616,195		$ 4,092,013
Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Share holders in the case of ISOs																		110.00%
Minimum [Member]
Stockholders’ Equity (Details) [Line Items]
Share holders in the case of ISOs																		10.00%
September 2020 Equity Raise [Member]
Stockholders’ Equity (Details) [Line Items]
Exercise price | $ / shares																																										$ 4.5
Principal | $																																										$ 3,183,667
Debt obligations | shares																																										768,204	768,204
Common stock exercise price. | $ / shares																																										$ 4.5
Warrant expiring																																										5 years	5 years
Underwriting discounts and commissions. | $																																										$ 7,762,500
Warrants to purchase. | $																																										570,416
Resulting in contingent BCF value | $																																										$ 3,051,810
IPO [Member] | September 2020 Equity Raise [Member]
Stockholders’ Equity (Details) [Line Items]
Price per unit | $ / shares																																										$ 4.5
Series E Convertible Preferred Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Preferred stock, description																														the Company entered into securities purchase agreements with thirty-three accredited investors whereby the Investors have agreed to purchase from the Company an aggregate of 7,778 shares of the Company’s Series E Convertible Preferred Stock, par value $0.001 per share and 2,831,715 warrants to purchase shares of the Company’s common stock, par value $0.001 per share. The Series E Preferred Stock is convertible into a total of 1,887,810 shares of Common Stock. The combined purchase price of one Conversion Share and one and a half warrant was $4.12. The aggregate purchase price for the Series E Preferred Stock and warrants was $7,777,777. The Company has recorded $817,353 to stock issuance costs, which are part of Additional Paid-in Capital.
Exercise price | $ / shares																														$ 4.5
Warrants, description																														The placement agent for the transaction and received cash compensation equal to 10% of the aggregate purchase price and warrants to purchase 471,953 shares of the Company’s common stock, at an exercise price of $5.15 per share (the “PA Warrants”). The PA Warrants are exercisable for a term of five-years from the date of issuance.
Subscription receivable | $																																										$ 40,000
Issuance cost | $																																										$ 4,225
Converted shares | shares																																										1,766,449	1,766,449
Warrants issued | shares																																										486,516	486,516
Settlement of Vendor Liabilities [Member]
Stockholders’ Equity (Details) [Line Items]
Restricted common stock issued, shares | shares																						250,000
The Second February 2020 [Member] | Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Convertible note outstanding | $														$ 125,000
Number of shares authorized to issue | shares														34,722
February 2019 [Member] | Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Convertible note outstanding | $														$ 70,542
Number of shares authorized to issue | shares														64,124
Interest on Convertible Debt, Net of Tax | $														$ 112,888
Convertible Notes [Member]
Stockholders’ Equity (Details) [Line Items]
Warrants issued | shares																																												214,080
Fair value of Warrants | $																																												$ 1,520,449
Notes Payable – Related Party [Member]
Stockholders’ Equity (Details) [Line Items]
Warrants issued | shares																																												289
Fair value of Warrants | $																																												$ 3,342